Yescarta
Ended Awarded
- Contract number
- 36C26024F0046
- Awardee
-
Gilead Sciences Inc. UEI FPJMGUK1BYH8
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $307,511
Award facts
- Contract value 100% obligated
- $307,511.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract awarded by the U.S. Department of Veterans Affairs (VA) to Gilead Sciences Inc. (Gilead), a prominent biopharmaceutical company. The contract, valued at $307,511.22, is a delivery order under Gilead's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. It provides the VA's Veterans Integrated Service Network (VISN) with the cancer immunotherapy drug YESCARTA. The contract has an ultimate completion date of October 31, 2023. Gilead is the prime contractor, and there is no small business set-aside designation for this award. This contract is part of Gilead's larger indefinite delivery vehicle (IDV) contracts with the VA, including a $29.16 million Blanket Purchase Agreement (BPA) specifically for procuring specialty medications like YESCARTA and Letairis, as well as a $33 million multiple-award Federal Supply Schedule contract. These IDVs demonstrate Gilead's strategic importance in supplying advanced medical treatments to federal healthcare programs, particularly for complex and life-threatening conditions affecting veterans.
Quick answers
Who was awarded contract 36C26024F0046?
36C26024F0046 was awarded to Gilead Sciences Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 5, 2023.
How much is contract 36C26024F0046 worth?
The government has obligated $307,511 on 36C26024F0046.
Is contract 36C26024F0046 an order under another contract?
Yes. 36C26024F0046 is a delivery order under V797D70252, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0046 competed?
The extent of competition for 36C26024F0046 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award